Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New cPLA2 inhibitors and their use reported by Wyeth in recent patent

July 4, 2003

Chiesi files IND to advance Formoterol Modulite into clinic

July 4, 2003

In vitro and in vivo profile of new orally active histamine H3 antagonist

July 2, 2003

Enrollment completed in phase II trial of SRP-299 for asthma

July 2, 2003

Three series of CCR3 antagonists with utility in asthma therapy claimed by Roche

June 30, 2003

Inhibitors of PDE4 and TNF-alpha production covered in Warner-Lambert patent

June 26, 2003

First humanized IgE-targeting antibody therapeutic approved for asthma

June 25, 2003

Novel inhibitors of CD23 production with utility in allergy, asthma, etc.

June 25, 2003

Hollis-Eden and CFFT study HE-2000 in cystic fibrosis

June 23, 2003

Bayer and PPL place hold on recombinant alpha1-antitrypsin development project

June 20, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...